305 related articles for article (PubMed ID: 16166655)
21. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max.
Amati B; Dalton S; Brooks MW; Littlewood TD; Evan GI; Land H
Nature; 1992 Oct; 359(6394):423-6. PubMed ID: 1406955
[TBL] [Abstract][Full Text] [Related]
22. The mechanism of discrimination between cognate and non-specific DNA by dimeric b/HLH/LZ transcription factors.
Sauvé S; Naud JF; Lavigne P
J Mol Biol; 2007 Jan; 365(4):1163-75. PubMed ID: 17109882
[TBL] [Abstract][Full Text] [Related]
23. The Max homodimeric b-HLH-LZ significantly interferes with the specific heterodimerization between the c-Myc and Max b-HLH-LZ in absence of DNA: a quantitative analysis.
McDuff FO; Naud JF; Montagne M; Sauvé S; Lavigne P
J Mol Recognit; 2009; 22(4):261-9. PubMed ID: 19189276
[TBL] [Abstract][Full Text] [Related]
24. Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain.
Ferré-D'Amaré AR; Prendergast GC; Ziff EB; Burley SK
Nature; 1993 May; 363(6424):38-45. PubMed ID: 8479534
[TBL] [Abstract][Full Text] [Related]
25. Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1.
Rao G; Alland L; Guida P; Schreiber-Agus N; Chen K; Chin L; Rochelle JM; Seldin MF; Skoultchi AI; DePinho RA
Oncogene; 1996 Mar; 12(5):1165-72. PubMed ID: 8649810
[TBL] [Abstract][Full Text] [Related]
26. Thermodynamics of b-HLH-LZ protein binding to DNA: the energetic importance of protein-DNA contacts in site-specific E-box recognition by the complete gene product of the Max p21 transcription factor.
Meier-Andrejszki L; Bjelić S; Naud JF; Lavigne P; Jelesarov I
Biochemistry; 2007 Oct; 46(43):12427-40. PubMed ID: 17915948
[TBL] [Abstract][Full Text] [Related]
27. The N-myc oncoprotein is a transcriptional activator and associates with max and RB1 proteins.
Wenzel A; Cziepluch C; Schürmann J; Schwab M
Prog Clin Biol Res; 1994; 385():59-66. PubMed ID: 7972238
[No Abstract] [Full Text] [Related]
28. Elucidation of the structural determinants responsible for the specific formation of heterodimeric Mxd1/Max b-HLH-LZ and its binding to E-box sequences.
Montagne M; Naud JF; Lavigne P
J Mol Biol; 2008 Feb; 376(1):141-52. PubMed ID: 18155722
[TBL] [Abstract][Full Text] [Related]
29. Identification of casein kinase II phosphorylation sites in Max: effects on DNA-binding kinetics of Max homo- and Myc/Max heterodimers.
Bousset K; Henriksson M; Lüscher-Firzlaff JM; Litchfield DW; Lüscher B
Oncogene; 1993 Dec; 8(12):3211-20. PubMed ID: 8247525
[TBL] [Abstract][Full Text] [Related]
30. Structural and thermodynamical characterization of the complete p21 gene product of Max.
Naud JF; McDuff FO; Sauvé S; Montagne M; Webb BA; Smith SP; Chabot B; Lavigne P
Biochemistry; 2005 Sep; 44(38):12746-58. PubMed ID: 16171389
[TBL] [Abstract][Full Text] [Related]
31. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif.
Hurlin PJ; Steingrìmsson E; Copeland NG; Jenkins NA; Eisenman RN
EMBO J; 1999 Dec; 18(24):7019-28. PubMed ID: 10601024
[TBL] [Abstract][Full Text] [Related]
32. Induction of apoptosis by the c-Myc helix-loop-helix/leucine zipper domain in mouse 3T3-L1 fibroblasts.
Kohlhuber F; Hermeking H; Graessmann A; Eick D
J Biol Chem; 1995 Dec; 270(48):28797-805. PubMed ID: 7499403
[TBL] [Abstract][Full Text] [Related]
33. Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosis.
Soucek L; Jucker R; Panacchia L; Ricordy R; Tatò F; Nasi S
Cancer Res; 2002 Jun; 62(12):3507-10. PubMed ID: 12067996
[TBL] [Abstract][Full Text] [Related]
34. Analysis of a variant Max sequence expressed in Xenopus laevis.
Tonissen KF; Krieg PA
Oncogene; 1994 Jan; 9(1):33-8. PubMed ID: 8302600
[TBL] [Abstract][Full Text] [Related]
35. Myc protein structure: localization of DNA-binding and protein dimerization domains.
Kerkhoff E; Bister K
Oncogene; 1991 Jan; 6(1):93-102. PubMed ID: 1992448
[TBL] [Abstract][Full Text] [Related]
36. v-Myc, but not Max, possesses domains that function in both transcription activation and cellular transformation.
Min S; Taparowsky EJ
Oncogene; 1992 Aug; 7(8):1531-40. PubMed ID: 1630816
[TBL] [Abstract][Full Text] [Related]
37. YY1 can inhibit c-Myc function through a mechanism requiring DNA binding of YY1 but neither its transactivation domain nor direct interaction with c-Myc.
Austen M; Cerni C; Lüscher-Firzlaff JM; Lüscher B
Oncogene; 1998 Jul; 17(4):511-20. PubMed ID: 9696045
[TBL] [Abstract][Full Text] [Related]
38. The leucine zippers of the HLH-LZ proteins Max and c-Myc preferentially form heterodimers.
Muhle-Goll C; Nilges M; Pastore A
Biochemistry; 1995 Oct; 34(41):13554-64. PubMed ID: 7577944
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence.
Giorello L; Clerico L; Pescarolo MP; Vikhanskaya F; Salmona M; Colella G; Bruno S; Mancuso T; Bagnasco L; Russo P; Parodi S
Cancer Res; 1998 Aug; 58(16):3654-9. PubMed ID: 9721875
[TBL] [Abstract][Full Text] [Related]
40. Lack of transcriptional repression by max homodimers.
Yin X; Grove L; Prochownik EV
Oncogene; 1998 May; 16(20):2629-37. PubMed ID: 9632139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]